Tessa M Andermann

10PUBLICATIONS
48CO-AUTHORS
Planning and decision makingCardiology (incl. cardiovascular diseases)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 04, 2026
Development and Application of an Anaerobic Activity Index.

|Jul 16, 2026
Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort Study.

|Feb 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.

Jakob Wirbel, Wael Saber, Michael J Martens

|Sep 22, 2025
Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in Adults.

Felicia Cao, Yueling Xiu, Michael Mohnasky

|Jan 16, 2025
The Prevalence of Multidrug Resistance in Enterobacterales Is Higher in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Tessa M Andermann, Dylan Brown, Thomas Holowka

|Nov 28, 2024
The impact of transplant location on the gut microbiome and resistome in patients undergoing hematopoietic stem cell transplantation at home versus in the hospital.

T M Andermann, K Zeng, S Guirales-Medrano

Pageof 2

Frequent Collaborators

3 joint publications

Natalie Grover

3 joint publications

Ami S Bhatt

3 joint publications

David van Duin

3 joint publications

Julia Messina